Logo Image
News
Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
Videos
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesFrom All AnglesOn Demand: WebinarsShorts
Conferences
Conference Coverage Conference Listing
Events
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
More
Resources
Advocacy GroupsArt GalleryCURE CookbookClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story

Subscribe

  • News
  • Videos
  • Conferences
  • Events
  • Resources
  • Subscribe
  • Blood Cancers
    • MPN
    • MDS
    • Myeloma
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Childhood Cancers
  • Gastrointestinal Cancers
    • Colorectal Cancer
    • Esophageal Cancer
    • Gastrointestinal stromal tumor
    • Liver Cancer
    • Pancreatic Cancer
  • Genitourinary Cancers
    • Bladder Cancer
    • Kidney Cancer
    • Prostate Cancer
  • Gynecologic Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head & Neck Cancer
  • Leukemia
    • Acute Myeloid Leukemia
    • CLL
  • Lung Cancer
  • Lymphoma
    • Follicular Lymphoma
    • Mantle Cell Lymphoma
    • Non-Hodgkin Lymphoma
  • Rare Cancers
    • Neuroendocrine Cancer
  • Sarcoma
  • Skin Cancer
    • Advanced Melanoma
  • Thyroid Cancer
Spotlight -
Blogs|
Breast Cancer Webinar Series|
Cancer Horizons|
Clinical Trial Corner|
Heal®|
Publications|
Videos
Advertisement

Carlos Doti, Vice President, Head of Medical Affairs, US Oncology, AstraZeneca

Advertisement

Articles by Carlos Doti, Vice President, Head of Medical Affairs, US Oncology, AstraZeneca

Closing Screening Gaps is Central to Revolutionizing Cancer Care

ByCarlos Doti, Vice President, Head of Medical Affairs, US Oncology, AstraZeneca
July 9th 2024

Sponsored Content

Advertisement

Latest Updated Articles

  • Closing Screening Gaps is Central to Revolutionizing Cancer Care
    Closing Screening Gaps is Central to Revolutionizing Cancer Care

    July 9th 2024



Advertisement
Advertisement

Trending on CURE

1

FDA Approves Tudriqev Plus Opdivo for Advanced Melanoma That Has Progressed After PD-1 Immunotherapy

2

9 Months After Surgery: Carolyn Rothfeld's Lung Cancer Story

3

After Breast Cancer, Finding the Time and Space to Live Again

4

When Insurance Denies Cancer Treatment: Finding Strength and Resilience After an Appeal Is Rejected

5

How Robotic Surgery Advances Have Enhanced Recovery in Patients With Lung Cancer

  • About Us
  • Advertise / Support
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • TargetedOnc.com
  • OncLive.com
  • OncNursingNews.com
  • Terms & Conditions
  • Privacy
  • Do Not Sell My Information
  • Washington My Health My Data
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.